Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Apellis And Sobi Announce Phase 3 VALIANT Study Results For Pegcetacoplan In Rare Kidney Diseases; Achieves 68% Reduction In Proteinuria, Consistent Across All Subgroups; Data Submission Planned For US And EU

Author: Benzinga Newsdesk | August 08, 2024 07:20am

Apellis To Host Conference Call At 8:00 AM ET

Posted In: APLS